KIOMED
LIVE

Serial Number

79203384

Owner

KiOmed Pharma, Société Anonyme

Attorney

Dmitriy O. Makarov

Filing Date

Sep 29, 2016

Add to watchlist:

No watchlists yet
View on USPTO

KIOMED Trademark

Serial Number: 79203384 • Registration: 5420385

KIOMED is a trademark filed by KiOmed Pharma, Société Anonyme on September 29, 2016. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 10 (Medical Apparatus), Class 42 (Computer & Scientific), Class 44 (Medical Services). The application is currently registered and active.

Owner Contact Info

KiOmed Pharma, Société Anonyme

Rue Haute Claire 4

Entity Type: 99

Trademark Details

Filing Date

September 29, 2016

Registration Date

March 13, 2018

Published for Opposition

December 26, 2017

Cancellation Date

September 27, 2024

Goods & Services

Chemicals, namely, chitosan, chitin, chitosan derivatives; chemicals, namely, chitin derivatives; chemical products for use in industry or science; chemical additives for manufacture of pharmaceutical products, vaccines and cosmetics; active chemical ingredients used in the manufacture of pharmaceutical products for treating musculo-sketletal disorders, dermal volumizing and dermatological disorders, eye disorder or eye tissue regeneration, acute and chronic diseases by achieving sustained and targeted delivery of the active, locally, intravenously or orally

Medical services; veterinary services; hygienic and beauty care for human beings or animals; medical assistance; cosmetic surgery; hospital services; nursing homes; convalescence or rest homes; opticians' services; alternative medicine services; health counseling services; medical equipment rental; telemedicine services; therapeutic services, namely therapeutic radiological services

Scientific services, namely research, testing, analysis and development services in the fields of medicine, pharmaceutical products, chemistry, biochemistry, biology, biotechnology or bacteriology; design and development of medical technologies; conducting clinical trials and preliminary evaluations for others , particularly for pharmaceutical products; evaluation of pharmaceutical products; scientific research and development services relating to vaccines and medicines; scientific research, analysis and development services in chemistry, biochemistry, biology, biotechnology or bacteriology; scientific research, analysis and development services in cosmetology; basic scientific research and clinical research in the fields of science, namely clinical trials and medicine; scientific research, testing and development of products developed using materials of vegetable origin; scientific research, testing and development of products developed using chitosan, chitin, chitosan derivatives of vegetable origin, chitin derivatives; carrying out technical or scientific studies in the fields of medicine, pharmaceutical products, chemistry, biochemistry, biology, biotechnology or bacteriology; provision of information and a database relating to scientific and medical research and development in the field of pharmaceutical products, chemistry, biochemistry, biology, biotechnology or bacteriology

Surgical, medical, dental and veterinary apparatus and instruments, namely, vertebral osteosynthesis staple-shaped apparatus and instruments, devices used in orthopedic surgery to position surgical instruments, implants and/or patients' limbs, orthopedic fixation device used in orthopedic transplant and/or implant surgery, surgical and medical apparatus and instruments for use in spinal, general, orthopedic surgery; artificial limbs, eyes and teeth; orthopedic articles, namely orthopedic cushions and braces, suture material; bone, joint, hip and breast prostheses, staple-shaped prostheses for the spinal column, staple-shaped prostheses of vertebral discs; artificial implants, namely to fill joints and bones, to fill the dermis and other conjunctival tissues, artificial implants to be used as surgical aids

Pharmaceutical preparations for the treatment and prevention of musculo-sketletal disorders, dermal volumizing and dermatological disorders, eye disorder or eye tissue regeneration, acute and chronic diseases by achieving sustained and targeted delivery of the active, locally, intravenously or orally; veterinary preparations for the treatment and prevention of musculo-sketletal disorders, dermal volumizing and dermatological disorders, eye disorder or eye tissue regeneration, acute and chronic diseases by achieving sustained and targeted delivery of the active, locally, intravenously or orally in farm animals and domestic pets; sanitary products for medical purposes; dietetic food and substances, namely, wheat-free and gluten-free pasta, crakers, bread to accommodate special medical and health conditions, dietetic sugar and infusion adapted for medical or veterinary use; materials for medical dressings; material for dental fillings and dental impressions; disinfectants for hygienic purposes, disinfectants for sanitary purposes, disinfectants for medical instruments; bath preparations for medical use; chemical preparations for medical or pharmaceutical use for the treatment and prevention of musculoskeletal disorders, dermal volumizing and dermatological disorders, eye disorder or eye tissue regeneration, acute and chronic diseases by achieving sustained and targeted delivery of the active, locally, intravenously or orally; pharmaceutical products based on materials of plant origin for the treatment and prevention of musculoskeletal disorders, dermal volumizing and dermatological disorders, eye disorder or eye tissue regeneration, acute and chronic diseases by achieving sustained and targeted delivery of the active, locally, intravenously or orally; pharmaceutical products based on chitosan, chitin, chitosan derivatives of vegetable origin, chitin derivatives for the treatment and prevention of musculoskeletal disorders, dermal volumizing and dermatological disorders, eye disorder or eye tissue regeneration, acute and chronic diseases by achieving sustained and targeted delivery of the active, locally, intravenously or orally; vaccines; preparations for vaccines

Filing History

TOTAL INVALIDATION PROCESSED BY THE IB
Oct 24, 2025 INNT
TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
Oct 2, 2025 INTS
INVALIDATION PROCESSED
Oct 2, 2025 INPC
TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
May 27, 2025 INTR
CANCELLED SECTION 71
Sep 27, 2024 C71T
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Mar 13, 2023 REM3
NEW REPRESENTATIVE AT IB RECEIVED
Mar 7, 2019 NREP
FINAL DECISION TRANSACTION PROCESSED BY IB
Jul 13, 2018 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Jun 19, 2018 FICS
FINAL DISPOSITION PROCESSED
Jun 19, 2018 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Jun 13, 2018 FICR
REGISTERED-PRINCIPAL REGISTER
Mar 13, 2018 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Dec 26, 2017 NPUB
PUBLISHED FOR OPPOSITION
Dec 26, 2017 PUBO
NOTIFICATION PROCESSED BY IB
Dec 22, 2017 GPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Dec 6, 2017 OPNS
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Dec 6, 2017 NONP
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Dec 6, 2017 OP2R
APPROVED FOR PUB - PRINCIPAL REGISTER
Nov 9, 2017 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Sep 22, 2017 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Sep 21, 2017 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Sep 21, 2017 TROA
REFUSAL PROCESSED BY IB
Apr 9, 2017 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Mar 23, 2017 RFCS
REFUSAL PROCESSED BY MPU
Mar 23, 2017 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Mar 22, 2017 RFCR
NON-FINAL ACTION WRITTEN
Mar 21, 2017 CNRT
APPLICATION FILING RECEIPT MAILED
Mar 21, 2017 MAFR
ASSIGNED TO EXAMINER
Mar 17, 2017 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Mar 17, 2017 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Mar 16, 2017 REPR